查看購物車
  • Simplified Chinese
  • English
亞太地區內皮功能障礙市場預測至 2028 年 - 區域分析 - 按原因、測試類型和最終用戶
市場調查報告書
商品編碼
1463689

亞太地區內皮功能障礙市場預測至 2028 年 - 區域分析 - 按原因、測試類型和最終用戶

Asia Pacific Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause, Test Type, and End User
出版日期: | 出版商: The Insight Partners | 英文 128 Pages | 訂單完成後即時交付

價格

亞太地區內皮CAGR障礙市場預計將從2022年的3.0448億美元成長到2028年的4.0551億美元。

新型生物標記和治療策略的使用不斷增加推動亞太內皮功能障礙市場

檢查內皮功能可以改善風險分層，改善早期疾病檢測，並評估血管對治療介入的反應。有研究旨在更好地了解內皮功能障礙和動脈粥樣硬化進展的病理生理機制，並確定新的生物標記和治療策略來預防內皮功能障礙和動脈粥樣硬化，從而降低患冠狀動脈疾病( CAD) 和相關併發症的風險。使用液體活體組織切片和新的分子生物學技術，可以鑑定出越來越多的內皮功能障礙的分子和細胞標記物，這些標記物可以深入了解動脈粥狀硬化的分子基礎，以及預防和治療動脈粥樣硬化和動脈粥狀硬化的潛在生物標記和治療標靶。

過去幾十年來，生物標記及其臨床應用的研究呈指數級成長。全身性生物標記為動脈粥狀硬化的病理生理學和新療法的開發提供了寶貴的見解。內皮功能障礙和發炎在 CAD 的發生和進展中發揮核心作用。發炎介質由動脈粥狀硬化斑塊中的發炎細胞和血管細胞或肝臟或脂肪組織等器官分泌。

亞太地區內皮功能障礙市場概述

亞太地區的內皮功能障礙市場分為中國、日本、印度、韓國、澳洲和亞太其他地區。該地區市場的成長歸因於內皮功能障礙病例的增加，心血管疾病、高血壓、糖尿病和慢性病發病率的上升，以及人口老化的加劇。此外，各國政府增加對診斷技術的投資推動了市場的發展，從而導致診斷方法的進步。

亞太地區內皮功能障礙市場收入及 2028 年預測（百萬美元）

亞太地區內皮功能障礙市場區隔

亞太地區內皮功能障礙市場按原因、測試類型、最終用戶和國家進行細分。

根據病因，亞太地區內皮功能障礙市場分為高血壓、高膽固醇血症、肥胖、糖尿病、白塞氏症等。 2022 年，高血壓細分市場在亞太地區內皮功能障礙市佔率最大。

根據測試類型，亞太地區內皮功能障礙市場分為侵入性測試和非侵入性測試。到2022 年，侵入性測試領域將在亞太地區內皮功能障礙市場中佔據更大佔有率。術、循環標記物等。

根據最終用戶，亞太地區內皮功能障礙市場可分為醫院、診斷中心、診所等。 2022 年，醫院細分市場佔據亞太地區最大的內皮功能障礙市場。

根據國家/地區，亞太地區內皮功能障礙市場分為中國、日本、印度、澳洲、韓國和亞太其他地區。 2022年，中國將主導亞太地區內皮功能障礙市場。

ZOLL Medical Corp、Sphingo Tec GmbH、Perimed AB 和 Medizinische Messtechnik GmbH 是該地區內皮功能障礙市場的一些領先公司。

目錄

表中的內容

第 1 章：簡介

第 2 章：亞太地區內皮功能障礙市場 - 要點

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：亞太地區內皮功能障礙市場 - 市場格局

  • 概述
  • PEST分析
    • 亞太地區 PEST 分析
  • 專家意見

第 5 章：亞太地區內皮功能障礙市場 - 主要市場動態

  • 市場促進因素
    • 心血管疾病發生率增加
    • 高膽固醇、糖尿病和肥胖症的發生率上升
  • 市場限制
    • 內皮功能障礙篩檢技術的缺點
  • 市場機會
    • 新型生物標記和治療策略的使用不斷增加
  • 未來的趨勢
    • 使用非侵入性方法評估內皮功能障礙
  • 影響分析

第 6 章：內皮功能障礙市場 - 亞太地區分析

  • 亞太地區內皮功能障礙市場收入預測與分析

第 7 章：亞太地區內皮功能障礙市場分析 - 按原因

  • 概述
  • 亞太地區內皮功能障礙市場，依原因分類，2022 年和 2028 年 (%)
  • 高血壓
  • 糖尿病
  • 高膽固醇血症
  • 白塞氏症
  • 肥胖
  • 其他

第 8 章：亞太地區內皮功能障礙市場分析 - 按測試類型

  • 概述
  • 亞太地區內皮功能障礙市場，依測試類型，2022 年和 2028 年 (%)
  • 侵入性測試
  • 非侵入性測試

第 9 章：亞太地區內皮功能障礙市場分析 - 按最終用戶

  • 概述
  • 亞太地區內皮功能障礙市場，按最終用戶分類，2022 年和 2028 年 (%)
  • 醫院
  • 診斷中心
  • 診所
  • 其他

第 10 章：亞太地區內皮功能障礙市場 - 收入與 2028 年預測 - 國家分析

  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區

第 11 章：亞太地區內皮功能障礙市場-產業格局

  • 概述
  • 內皮功能障礙市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 12 章：公司簡介

  • ZOLL Medical Corp
  • Sphingo Tec GmbH
  • Perimed AB
  • Medizinische Messtechnik GmbH

第 13 章：附錄

Product Code: BMIRE00029598

The Asia Pacific endothelial dysfunction market is expected to grow from US$ 304.48 million in 2022 to US$ 405.51 million by 2028. It is estimated to grow at a CAGR of 4.9% from 2022 to 2028.

Rising Usage of Novel Biomarkers and Therapeutic Strategies Fuels Asia Pacific Endothelial Dysfunction Market

Examining endothelial function can improve risk stratification, improve early disease detection, and assess vascular response to therapeutic interventions. There are studies to understand the pathophysiological mechanisms underlying endothelial dysfunction and atherosclerosis progression in a better way and identify new biomarkers and therapeutic strategies to prevent endothelial dysfunction and atherosclerosis to reduce the risk of developing coronary artery disease (CAD) and related complications. Using liquid biopsies and new molecular biology techniques has enabled the identification of a growing list of molecular and cellular markers of endothelial dysfunction that have provided insight into the molecular basis of atherosclerosis as well as potential biomarkers and therapeutic targets for the prevention and treatment of atherosclerosis and CAD.

Research on biomarkers and their clinical application has increased exponentially over the last few decades. Invaluable insight into the pathophysiology of atherosclerosis and the development of novel therapies have been provided by systemic biomarkers. Endothelial dysfunction and inflammation play a central role in the development and progression of CAD. Inflammatory mediators are secreted by inflammatory and vascular cells in atherosclerotic plaque or by organs such as the liver or adipose tissue.

Asia Pacific Endothelial Dysfunction Market Overview

The endothelial dysfunction market in Asia Pacific is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of the market in the region is attributed to the increasing cases of endothelial dysfunction with the rising incidence of CVD, hypertension, diabetes, and chronic diseases, coupled with the growing aging population. In addition, the market is driven by increasing investments in diagnostics techniques by the respective country governments, resulting in advancements in diagnostics methods.

Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Endothelial Dysfunction Market Segmentation

The Asia Pacific endothelial dysfunction market is segmented into cause, test type, end user, and country.

Based on cause, the Asia Pacific endothelial dysfunction market is segmented into hypertension, hypercholesterolaemia, obesity, diabetes, Behcet's disease, and others. The hypertension segment registered the largest Asia Pacific endothelial dysfunction market share in 2022.

Based on test type, the Asia Pacific endothelial dysfunction market is segmented into invasive test and non-invasive test. The invasive test segment held a larger Asia Pacific endothelial dysfunction market share in 2022. The non-invasive test segment is further subsegmented into flow mediated dilatory, peripheral arterial tonometry (PAT), venous occlusion pletismography, circulating markers, and others.

Based on end user, the Asia Pacific endothelial dysfunction market has been categorized into hospitals, diagnostic centers, clinics, and others. The hospitals segment held the largest Asia Pacific endothelial dysfunction market share in 2022.

Based on country, the Asia Pacific endothelial dysfunction market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific endothelial dysfunction market in 2022.

ZOLL Medical Corp, Sphingo Tec GmbH, Perimed AB, and Medizinische Messtechnik GmbH are some of the leading companies operating in the endothelial dysfunction market in the region.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Endothelial Dysfunction Market - by Cause
    • 1.3.2 Asia Pacific Endothelial Dysfunction Market - by Test Type
    • 1.3.3 Asia Pacific Endothelial Dysfunction Market - by End User
    • 1.3.4 Asia Pacific Endothelial Dysfunction Market - by Country

2. Asia Pacific Endothelial Dysfunction Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Endothelial Dysfunction Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Asia Pacific PEST Analysis
  • 4.3 Expert Opinion

5. Asia Pacific Endothelial Dysfunction Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidences of Cardiovascular Diseases
    • 5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
  • 5.2 Market Restraints
    • 5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
  • 5.3 Market Opportunities
    • 5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
  • 5.4 Future Trends
    • 5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
  • 5.5 Impact Analysis

6. Endothelial Dysfunction Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Endothelial Dysfunction Market Revenue Forecast and Analysis

7. Asia Pacific Endothelial Dysfunction Market Analysis - by Cause

  • 7.1 Overview
  • 7.2 Asia Pacific Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
  • 7.3 Hypertension
    • 7.3.1 Overview
    • 7.3.2 Hypertension: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Diabetes
    • 7.4.1 Overview
    • 7.4.2 Diabetes: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Hypercholestrolaemia
    • 7.5.1 Overview
    • 7.5.2 Hypercholestrolaemia: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Behcet's Disease
    • 7.6.1 Overview
    • 7.6.2 Behcet's Disease: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Obesity
    • 7.7.1 Overview
    • 7.7.2 Obesity: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Endothelial Dysfunction Market Analysis - by Test Type

  • 8.1 Overview
  • 8.2 Asia Pacific Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
  • 8.3 Invasive Tests
    • 8.3.1 Overview
    • 8.3.2 Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Non-Invasive Tests
    • 8.4.1 Overview
    • 8.4.2 Non-Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.3 Flow Mediated Dilatory
      • 8.4.3.1 Overview
      • 8.4.3.2 Flow Mediated Dilatory: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.4 Venous Occlusion Plethysmography
      • 8.4.4.1 Overview
      • 8.4.4.2 Venous Occlusion Plethysmography: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.5 Peripheral Arterial Tonometry (PAT)
      • 8.4.5.1 Overview
      • 8.4.5.2 Peripheral Arterial Tonometry (PAT): Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.6 Circulating Markers
      • 8.4.6.1 Overview
      • 8.4.6.2 Circulating Markers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.7 Others
      • 8.4.7.1 Overview
      • 8.4.7.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Endothelial Dysfunction Market Analysis - by End User

  • 9.1 Overview
  • 9.2 Asia Pacific Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Diagnostics Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostics Centers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Clinics
    • 9.5.1 Overview
    • 9.5.2 Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 Asia Pacific: Endothelial Dysfunction Market
    • 10.1.1 Overview
      • 10.1.1.1 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 China: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.1.4 China: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.1.1.1.4.1 China: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.1.1.1.5 China: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 Japan: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.2.4 Japan: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.1.1.2.4.1 Japan: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.1.1.2.5 Japan: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.3 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 India: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.3.4 India: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.1.1.3.4.1 India: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.1.1.3.5 India: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.4 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.3 Australia: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.4.4 Australia: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.1.1.4.4.1 Australia: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.1.1.4.5 Australia: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.5 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.3 South Korea: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.5.4 South Korea: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.1.1.5.4.1 South Korea: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.1.1.5.5 South Korea: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.6 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.3 Rest of Asia Pacific: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.6.4 Rest of Asia Pacific: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
        • 10.1.1.6.4.1 Rest of Asia Pacific: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
        • 10.1.1.6.5 Rest of Asia Pacific: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

11. Asia Pacific Endothelial Dysfunction Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Endothelial Dysfunction Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 ZOLL Medical Corp
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Sphingo Tec GmbH
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Perimed AB
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Medizinische Messtechnik GmbH
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Techniques Used in to Assess Endothelial Function
  • Table 2. Novel Soluble and Cell Component Biomarkers of Endothelia Dysfunction in Cardiovascular Diseases
  • Table 3. China Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. China Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. China Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. China Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Japan Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Japan Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Japan Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Japan Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. India Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. India Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. India Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 14. India Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Australia Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Australia Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Australia Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Australia Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. South Korea Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. South Korea Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. South Korea Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 22. South Korea Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. Rest of Asia Pacific Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. Rest of Asia Pacific Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Rest of Asia Pacific Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Rest of Asia Pacific Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Recent Inorganic Growth Strategies in the Endothelial Dysfunction Market
  • Table 28. Recent Organic Growth Strategies in the Endothelial Dysfunction Market
  • Table 29. Glossary of Terms, Endothelial dysfunction market

List Of Figures

  • Figure 1. Asia Pacific Endothelial Dysfunction Market Segmentation
  • Figure 2. Asia Pacific Endothelial Dysfunction Market, by Country
  • Figure 3. Asia Pacific Endothelial Dysfunction Market Overview
  • Figure 4. Hypertension Account for Largest Share of Cause Segment in Asia Pacific Endothelial Dysfunction Market
  • Figure 5. China Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Asia Pacific: PEST Analysis
  • Figure 7. Expert Opinion
  • Figure 8. Asia Pacific Endothelial Dysfunction Market: Impact Analysis of Drivers and Restraints
  • Figure 9. Asia Pacific Endothelial Dysfunction Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. Asia Pacific Endothelial Dysfunction Market, by Cause, 2022 & 2028 (%)
  • Figure 11. Hypertension: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Diabetes: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Hypercholestrolaemia: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Behcet's disease: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Obesity: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Asia Pacific Endothelial Dysfunction Market, by Test Type, 2022 & 2028 (%)
  • Figure 18. Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Non-Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Flow Mediated Dilatory: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Venous Occlusion Plethysmography: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Peripheral Arterial Tonometry (PAT): Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Circulating Markers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Asia Pacific Endothelial Dysfunction Market, by End User, 2022 & 2028 (%)
  • Figure 26. Hospitals and Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Diagnostics Centers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Asia Pacific: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. Asia Pacific: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
  • Figure 32. China: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. India: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Growth Strategies in the Endothelial Dysfunction Market